Related Experiment Video
Updated: Jul 1, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Synergistic Geroprotectors Mapping through Systems Machine Learning and Graph Neural Networks
1Department of Biotechnology, Delhi Technological University, Delhi, India.
Abstract:
Geroscience offers a transformative paradigm by targeting shared aging hallmarks to enable simultaneous modulation of multiple age-related disorders (ARDs). Yet, current geroprotective interventions often lack mechanistic breadth, as targeting isolated pathways yields limited benefits compared to interventions modulating interconnected regulators of aging biology. To bridge this gap, a systems-level strategy was designed around four key targets, including, Nrf2/Keap1, mTORC1, AMPK, and SIRT1, responsible for regulating oxidative stress, mitochondrial dysfunction, proteostasis, and autophagy. Concurrent regulation of these targets was identified to potentially induce a concerted and sustained geroprotective effect across diverse ARDs. A machine learning-based geroprotector classification model was developed to identify natural compounds capable of executing this integrated strategy. Subsequent drug-likeness screening confirmed favorable pharmacokinetic properties of the predicted compounds, while molecular docking revealed compounds with strong binding affinities with all four geroprotective targets, thereby leading to the identification of a subset of natural compounds with the potential to induce a coordinated geroprotective response. Finally, a graph neural network-based synergy prediction model, trained on known ARD drug combinations, identified five high-confidence pairs composed of four natural compounds, including Baicalein, Pectolinarigenin, Phloretin, and Demethoxycurcumin. These computationally predicted combinations hold the potential to elicit synergistic and comprehensive geroprotective effects across multiple ARDs.
Insights
This study identifies natural compounds that target key aging pathways simultaneously. These compounds show potential for synergistic effects, offering a new strategy to combat multiple age-related disorders comprehensively.
Area of Science:
- Geroscience
- Computational Biology
- Pharmacology
Background:
- Aging hallmarks are shared across multiple age-related disorders (ARDs).
- Current geroprotective interventions often lack mechanistic breadth, targeting isolated pathways.
- A systems-level strategy is needed to modulate interconnected aging biology regulators.
Purpose of the Study:
- To design a systems-level strategy targeting four key aging regulators: Nrf2/Keap1, mTORC1, AMPK, and SIRT1.
- To identify natural compounds capable of executing this integrated geroprotective strategy using machine learning.
- To predict synergistic combinations of natural compounds for comprehensive geroprotection.
Main Methods:
- Developed a machine learning model to classify geroprotectors targeting Nrf2/Keap1, mTORC1, AMPK, and SIRT1.
- Performed drug-likeness screening and molecular docking to assess compound properties and target binding.
- Utilized a graph neural network model to predict synergistic combinations of natural compounds for ARDs.
Main Results:
- Identified a subset of natural compounds with favorable pharmacokinetics and strong binding affinities to all four geroprotective targets.
- Predicted five high-confidence synergistic pairs of natural compounds, including Baicalein, Pectolinarigenin, Phloretin, and Demethoxycurcumin.
- Demonstrated the potential for a coordinated geroprotective response across diverse ARDs.
Conclusions:
- A systems-level approach targeting multiple aging hallmarks can yield sustained geroprotective effects.
- Computational methods can effectively identify natural compounds and combinations for integrated geroprotection.
- Predicted natural compound combinations offer a promising strategy for synergistic and comprehensive treatment of multiple ARDs.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmacogenomics: Identification of New Drug Targets
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics and Pharmacogenomics: Overview
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
